Cardiol Therapeutics (CRDL) Drug Pipeline
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Cardiolrx | Recurrent Pericarditis | Phase III | Recruiting | CardiolRx in Recurrent Pericarditis Following IL-1 Blocker Cessation | Nov 25, 2024 | ― |
| Cardiolrx | Recurrent Pericarditis | Phase II | Completed | Impact of CardiolRxTM on Recurrent Pericarditis (MAvERIC-Pilot) | Aug 08, 2022 | ― |
| Cardiolrx | Acute Myocarditis | Phase II | Completed | Impact of CardiolRx on Myocardial Recovery in Patients With Acute Myocarditis | Sep 25, 2021 | ― |
| Cannabidiol, Pharmaceutically Produced With < 5 Ppm Thc | Cardiovascular Diseases, Covid-19, Cardiovascular Risk Factor | phase2AndPhase3 | Terminated | Cannabidiol in Patients With COVID-19 and Cardiovascular Disease or Risk Factors | Nov 02, 2020 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Cardiolrx | Phase III | Recurrent Pericarditis | Recruiting | CardiolRx in Recurrent Pericarditis Following IL-1 Blocker Cessation | Nov 25, 2024 | ― |
| Cardiolrx | Phase II | Recurrent Pericarditis | Completed | Impact of CardiolRxTM on Recurrent Pericarditis (MAvERIC-Pilot) | Aug 08, 2022 | ― |
| Cardiolrx | Phase II | Acute Myocarditis | Completed | Impact of CardiolRx on Myocardial Recovery in Patients With Acute Myocarditis | Sep 25, 2021 | ― |
| Cannabidiol, Pharmaceutically Produced With < 5 Ppm Thc | phase2AndPhase3 | Cardiovascular Diseases, Covid-19, Cardiovascular Risk Factor | Terminated | Cannabidiol in Patients With COVID-19 and Cardiovascular Disease or Risk Factors | Nov 02, 2020 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Cardiol Therapeutics Inc. (CRDL) have in its pipeline
Cardiol Therapeutics CRDL is currently developing the following drugs: Cardiolrx, Cannabidiol, Pharmaceutically Produced With < 5 Ppm Thc. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
